AI assistant
Immuron Ltd — Investor Presentation 2008
Oct 29, 2008
35121_rns_2008-10-29_899d905d-0e01-4e20-baae-2315a46e23aa.pdf
Investor Presentation
Open in viewerOpens in your device viewer
==> picture [186 x 44] intentionally omitted <==
Anadis to Present at the Rodman & Rensaw 5th Annual Global Healthcare Conference
Thursday 30 October 2008
Melbourne and New York, October 30, 2008 - Anadis Limited today announced that Dr. Zeil Rosenberg, CEO, and Dr. Oren Fuerst , VP Business Development, will present a company overview at the Rodman & Renshaw 10th Annual Healthcare Conference in New York's Palace Hotel. The presentation will take place at 3:40PM EST on Wednesday, November 12th, 2008.
Anadis Limited (ANX.AX; ANDIY.PK; CUSIP: 032517104) is a biopharmaceutical company focused on antigen-primed, dairy-derived health products. Anadis’ proprietary and low-cost antibody manufacturing technology enables it to rapidly develop polyclonal antibody and other protein-based oral therapies to a range of important infectious and immune- mediated diseases.
Contact:
Dr. Oren Fuerst- VP, Business Development Email: [email protected] Tel +1 646 259 3321
Gran Rawlin – VP, Research and Development Email: [email protected] Tel: +61 3 9018 4880
Arie Nudel- Investor Relations Email: [email protected] Tel: +61 3 9014 4880
USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118 Tel 646 402 5289 Fax 646 390 3238
AUSTRALIA L1 39 Levenson St, North Melbourne, VICTORIA, 3051 Tel (61) 3 9018 4880 Fax (61) 3 9018 4881